Publications

Oral presentation presented at the 23^rd DKVF Conference, Potsdam, Germany

This systematic literature review aimed to aggregate existing research on
correlates and mechanisms that contribute to self-stigmatization
among people with atopic dermatitis, psoriasis, vitiligo, alopecia areata or hidradenitis suppurativa and to, ultimately, identify targets for psychosocial interventions.

Certified CME training by the German Academy of Dermatology.

Dermatillomania requires specialist knowledge, a correct diagnosis and a lot of time for sensitive and differentiated exploration by the practitioner. According to current research, the treatment of choice is cognitive behavioural therapy, in particular habit reversal training.

Oral presentation presented at the 23^rd DKVF Conference, Potsdam, Germany

Women of childbearing age (WoCBA) with psoriasis face additional burden related to contraindications of systemic treatments during pregnancy/lactation and to the physical and psychosocial impact of psoriasis on their intimate/sexual relationships.

Within a people-centered health care model, this study aimed to identify specific patient needs and their correlates in WoCBA (18–45 years), in comparison to same-age men and women above 45 years.

Oral presentation presented at the 31^st Annual Conference of ISOQOL, Cologne, Germany

Poster presented at the 33^rd EADV Congress, Amsterdam, the Netherlands

Poster presented at the 33^rd EADV Congress, Amsterdam, the Netherlands

Skin diseases in patients with skin of colour (Fitzpatrick skin types IV to VI) are underrepresented in dermatology training, which may lead to lower quality of care for these patients. To address this underrepresentation in medical education, a newly developed seminar on skin type diversity using an interactive teaching method was implemented in an undergraduate medical curriculum. This study examined the effects of a seminar on the self-assessed competence of medical students in managing skin conditions in patients with skin of colour.

Vitiligo is a common disorder characterized by the visible loss of skin pigmentation. Non-segmental vitiligo (NSV) is the major subtype. The disease is caused by autoimmune-mediated destruction of melanocytes. Vitiligo leads to stigmatization and a significant reduction in quality of life. We recommend optimizing care by incorporating the assessment of quality of life as a standard in routine care, in addition to monitoring disease activity.